{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Wistar rats", "anticancer drugs", "cisplatin", "hematological and biochemical parameters", "principal component analysis", "resveratrol", "side effects", "\u03b3-cyclodextrin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37893100", "DateRevised": {"Year": "2023", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["2726", "10.3390/biomedicines11102726"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "11", "Issue": "10", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "08"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Beneficial Effects of Resveratrol and \u03b3-Cyclodextrin on the Hematological and Biochemical Parameters of Healthy Wistar Rats Treated with Cisplatin: A PCA Approach.", "Abstract": {"AbstractText": ["It is well known that platinum-based antineoplastic agents, including cisplatin (CP), have side effects that limit their use. Nefrotoxicity, neurotoxicity, and hemolytic anemia are the most common side effects. There are few studies on the reduction in these effects that involves nanoencapsulation; however, almost none involve cyclodextrins (CDs). Changes in the hematological and biochemical parameters of healthy Wistar rats treated with solutions of \u03b3-cyclodextrin/resveratrol/cisplatin (\u03b3-CD/Rv/CP) ternary complexes are investigated for the first time. They are intraperitoneally injected with \u03b3-CD/Rv/CP solutions containing 5 mg CP/kg.b.w. Single shots were administered to six groups of Wistar rats (six individuals for every group) using \u03b3-CD/Rv/CP, \u03b3-CD/CP, \u03b3-CD/Rv complexes, as well as positive- and negative-control groups, respectively. Thirty-two hematological and biochemical parameters were evaluated from blood samples and used as input variables for the principal component analysis (PCA) discrimination of the groups. The best protection was obtained for the \u03b3-CD/Rv/CP ternary complex, which determined closer biochemical values to the control group. These values significantly differ from those of the \u03b3-CD/CP treated group, especially for the IP, UA, and T-Pro kidney-related biochemical parameters. This finding proves the beneficial influence of Rv during CP administration through CD-based carriers."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science, University of Life Sciences \"King Mihai I\" from Timisoara, Calea Aradului 119, 300645 Timisoara, Romania."}], "LastName": "H\u0103d\u0103rug\u0103", "ForeName": "Nicoleta-Gabriela", "Initials": "NG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Working Group for Xenobiochemistry, Romanian Academy-Timisoara Branch, Mihai Viteazu Bd. 24, 300223 Timisoara, Romania."}], "LastName": "G\u00e2rban", "ForeName": "Zeno", "Initials": "Z"}, {"Identifier": ["0000-0001-5734-0071"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "\"Aurel Ardelean\" Institute of Life Sciences, \"Vasile Goldis\" Western University, Liviu Rebreanu 86, 310414 Arad, Romania."}], "LastName": "Balt\u0103", "ForeName": "Cornel", "Initials": "C"}, {"Identifier": ["0000-0003-2907-4233"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Toxicoses, Plant Biology and Medicinal Plants, University of Life Sciences \"King Mihai I\" from Timisoara, Calea Aradului 119, 300645 Timisoara, Romania."}], "LastName": "Muselin", "ForeName": "Florin", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, Organic and Natural Compounds Engineering, Polytechnic University of Timisoara, Carol Telbisz 6, 300001 Timisoara, Romania."}], "LastName": "H\u0103d\u0103rug\u0103", "ForeName": "Daniel-Ioan", "Initials": "DI"}, {"Identifier": ["0000-0001-5626-1064"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anesthesiology and Oral Surgery, \"Victor Babes\" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. 2, 300041 Timisoara, Romania."}], "LastName": "Rivi\u015f", "ForeName": "Mircea", "Initials": "M"}], "GrantList": [{"GrantID": "PN2 PCCE 140 / 2008", "Agency": "Ministry of Education, Research, Youth, and Sports from Romania", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hassanpour S.H., Dehghani M. Review of cancer from perspective of molecular. J. Cancer Res. Pract. 2017;4:127\u2013129. doi: 10.1016/j.jcrpr.2017.07.001.", "ArticleIdList": ["10.1016/j.jcrpr.2017.07.001"]}, {"Citation": "WHO Collaborating Centre for Drug Statistics Methodology  . ATC/DDD Index 2023. Norwegian Institute of Public Health; Oslo, Norway: 2023.  [(accessed on 3 August 2023)].  Available online:  https://www.whocc.no/atc_ddd_index."}, {"Citation": "Gasser G., Ott I., Metzler-Nolte N. Organometallic Anticancer Compounds. J. Med. Chem. 2011;54:3\u201325. doi: 10.1021/jm100020w.", "ArticleIdList": ["10.1021/jm100020w", "PMC3018145", "21077686"]}, {"Citation": "Scattolin T., Voloshkin V.A., Visentin F., Nolan S.P. A critical review of palladium organometallic anticancer agents. Cell Rep. Phys. Sci. 2021;2:100446. doi: 10.1016/j.xcrp.2021.100446.", "ArticleIdList": ["10.1016/j.xcrp.2021.100446"]}, {"Citation": "Zhang P., Sadler P.J. Advances in the design of organometallic anticancer complexes. J. Organomet. Chem. 2017;839:5\u201314. doi: 10.1016/j.jorganchem.2017.03.038.", "ArticleIdList": ["10.1016/j.jorganchem.2017.03.038"]}, {"Citation": "Pinzani V., Bressolle F., Haug I.J., Galtier M., Blayac J.P., Balm\u00e8s P. Cisplatin-induced renal toxicity and toxicity-modulating strategies: A review. Cancer Chemother. Pharmacol. 1994;35:1\u20139.", "ArticleIdList": ["7987972"]}, {"Citation": "Corbeau A., Kuipers S.C., de-Boer S.M., Horeweg N., Hoogeman M.S., Godart J., Nout R.A. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: A systematic review. Radiother. Oncol. 2021;164:128\u2013137. doi: 10.1016/j.radonc.2021.09.009.", "ArticleIdList": ["10.1016/j.radonc.2021.09.009", "34560187"]}, {"Citation": "De-Felice F., Belgioia L., Alterio D., Bonomo P., Maddalo M., Paiar F., Denaro N., Corv\u00f2 R., Merlotti A., Bossi P., et al. Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Crit. Rev. Oncol./Hematol. 2021;162:103345. doi: 10.1016/j.critrevonc.2021.103345.", "ArticleIdList": ["10.1016/j.critrevonc.2021.103345", "33933569"]}, {"Citation": "Leite E.A., Giuberti C.d.S., Wainstein A.J.A., Wainstein A.P.D.L., Coelho L.G.V., Lana \u00c2.M.Q., Savassi-Rocha P.R., De-Oliveira M.C. Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration. Life Sci. 2009;84:641\u2013649. doi: 10.1016/j.lfs.2009.02.002.", "ArticleIdList": ["10.1016/j.lfs.2009.02.002", "19302806"]}, {"Citation": "Shruthi S., Shenoy K.B. Septilin: A versatile anticlastogenic, antigenotoxic, antioxidant and histoprotective herbo-mineral formulation on cisplatin-induced toxicity in mice. Mutat. Res.-Genet. Toxicol. Environ. Mutagen. 2022;874\u2013875:503441. doi: 10.1016/j.mrgentox.2022.503441.", "ArticleIdList": ["10.1016/j.mrgentox.2022.503441", "35151427"]}, {"Citation": "Souza L.F., Pagno C.H., Medeiros N.d.S., Barbosa S., dos-Santos P.C.P., Rios A., Achaval M., de-Jong E.V. The effect of the carotenoid bixin and annatto seeds on hematological markers and nephrotoxicity in rats subjected to chronic treatment with cisplatin. Rev. Bras. Farmacogn. 2016;26:446\u2013450. doi: 10.1016/j.bjp.2016.03.005.", "ArticleIdList": ["10.1016/j.bjp.2016.03.005"]}, {"Citation": "Jia Y., Zhou D., Jia Q., Ying Y., Chen S. Synergistic and attenuated effect of HSS in combination treatment with docetaxel plus cisplatin in human non-small-cell lung SPC-A-1 tumor xenograft. Biomed. Pharmacother. 2016;79:27\u201334. doi: 10.1016/j.biopha.2016.01.043.", "ArticleIdList": ["10.1016/j.biopha.2016.01.043", "27044809"]}, {"Citation": "Weijl N.I., Elsendoorn T.J., Lentjes E.G.W.M., Hopman G.D., Wipkink-Bakker A., Zwinderman A.H., Cleton F.J., Osanto S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: A randomised, double-blind, placebo-controlled study. Eur. J. Cancer. 2004;40:1713\u20131723. doi: 10.1016/j.ejca.2004.02.029.", "ArticleIdList": ["10.1016/j.ejca.2004.02.029", "15251161"]}, {"Citation": "Gidwani B., Vyas A. A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs. BioMed Res. Int. 2015;2015:198268. doi: 10.1155/2015/198268.", "ArticleIdList": ["10.1155/2015/198268", "PMC4637021", "26582104"]}, {"Citation": "Adeli M., Hakimpoor F., Parsamanesh M., Kalantari M., Sobhani Z., Attyabi F. Quantum dot-pseudopolyrotaxane supramolecules as anticancer drug delivery systems. Polymer. 2011;52:2401\u20132413. doi: 10.1016/j.polymer.2011.02.032.", "ArticleIdList": ["10.1016/j.polymer.2011.02.032"]}, {"Citation": "Tian B., Hua S., Liu J. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review. Carbohydr. Polym. 2020;2020:115805. doi: 10.1016/j.carbpol.2019.115805.", "ArticleIdList": ["10.1016/j.carbpol.2019.115805", "31952603"]}, {"Citation": "Tian B., Liu Y., Liu J. Chitosan-based nanoscale and non-nanoscale delivery systems for anticancer drugs: A review. Eur. Polym. J. 2021;154:110533. doi: 10.1016/j.eurpolymj.2021.110533.", "ArticleIdList": ["10.1016/j.eurpolymj.2021.110533"]}, {"Citation": "Altoom N., Ibrahim S.M., Othman S.I., Allam A.A., Alqhtani H.A., Al-Otaibi F.S., Abukhadra M.R. Characterization of \u03b2-cyclodextrin/phillipsite (\u03b2-CD/Ph) composite as a potential carrier for oxaliplatin as therapy for colorectal cancer; loading, release, and cytotoxicity. Colloids Surf. A Physicochem. Eng. Asp. 2022;648:129144. doi: 10.1016/j.colsurfa.2022.129144.", "ArticleIdList": ["10.1016/j.colsurfa.2022.129144"]}, {"Citation": "Upadhyay A.K., Singh S., Chhipa R.R., Vijayakumar M.V., Ajay A.K., Bhat M.K. Methyl-\u03b2-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: Involvement of Akt, NF-\u03baB and Bcl-2. Toxicol. Appl. Pharmacol. 2006;216:177\u2013185. doi: 10.1016/j.taap.2006.05.009.", "ArticleIdList": ["10.1016/j.taap.2006.05.009", "16806341"]}, {"Citation": "Utsuki T., Brem H., Pitha J., Loftsson T., Kristmundsdottir T., Tyler B.M., Olivi A. Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl \u03b1-cyclodextrin. J. Control. Release. 1996;40:251\u2013260. doi: 10.1016/0168-3659(95)00192-1.", "ArticleIdList": ["10.1016/0168-3659(95)00192-1"]}, {"Citation": "Zhang D., Zhang J., Jiang K., Li K., Cong Y., Pu S., Jin Y., Lin J. Preparation, characterisation and antitumour activity of \u03b2-, \u03b3- and HP-\u03b2-cyclodextrin inclusion complexes of oxaliplatin. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2016;152:501\u2013508. doi: 10.1016/j.saa.2015.07.088.", "ArticleIdList": ["10.1016/j.saa.2015.07.088", "26254603"]}, {"Citation": "Matencio A., Dhakar N.K., Bessone F., Musso G., Cavalli R., Dianzani C., Garc\u00eda-Carmona F., L\u00f3pez-Nicol\u00e1s J.M., Trotta F. Study of oxyresveratrol complexes with insoluble cyclodextrin based nanosponges: Developing a novel way to obtain their complexation constants and application in an anticancer study. Carbohydr. Polym. 2020;231:115763. doi: 10.1016/j.carbpol.2019.115763.", "ArticleIdList": ["10.1016/j.carbpol.2019.115763", "31888848"]}, {"Citation": "Soo E., Thakur S., Qu Z., Jambhrunkar S., Parekh H.S., Popat A. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach. J. Colloid Interface Sci. 2016;462:368\u2013374. doi: 10.1016/j.jcis.2015.10.022.", "ArticleIdList": ["10.1016/j.jcis.2015.10.022", "26479200"]}, {"Citation": "Venuti V., Cannav\u00e0 C., Cristiano M.C., Fresta M., Majolino D., Paolino D., Stancanelli R., Tommasini S., Ventura C.A. A characterization study of resveratrol/sulfobutylether-\u03b2-cyclodextrin inclusion complex and in vitro anticancer activity. Colloids Surf. B Biointerfaces. 2014;115:22\u201328. doi: 10.1016/j.colsurfb.2013.11.025.", "ArticleIdList": ["10.1016/j.colsurfb.2013.11.025", "24321846"]}, {"Citation": "Balaji A., Pandey V.P., Srinath M.S., Manavalan R. Cytotoxic evaluation of cisplatin, cisplatin/hydroxypropyl-\u03b2-cyclodextrin complexes and their nanoparticles drug delivery systems. Biomed. Pharmacol. J. 2008;1:341\u2013348."}, {"Citation": "Darini A., Eslaminejad T., Mahani S.N.N., Ansari M. Magnetogel Nanospheres Composed of Cisplatin-Loaded Alginate/\u03b2-Cyclodextrin as Controlled Release Drug Delivery. Adv. Pharm. Bull. 2019;9:571\u2013577. doi: 10.15171/apb.2019.065.", "ArticleIdList": ["10.15171/apb.2019.065", "PMC6912182", "31857960"]}, {"Citation": "Du X.-F., Li Y., Long J., Zhang W., Wang D., Li C.-R., Zhao M.-X., Lai Y. Fabrication of cisplatin-loaded polydopamine nanoparticles via supramolecular self-assembly for photoacoustic imaging guided chemo-photothermal cancer therapy. Appl. Mater. Today. 2021;23:101019. doi: 10.1016/j.apmt.2021.101019.", "ArticleIdList": ["10.1016/j.apmt.2021.101019"]}, {"Citation": "Panyosak A. The Behavior of Nanovesicles of Physicochemical Profiles: Compose of \u03b2-Cyclodextrin and Cisplatin for Anti-Tumor Activity and Decrease Toxicity Affected Normal Surrounding Tumor Tissues. Trends Sci. 2023;20:4293. doi: 10.48048/tis.2023.4293.", "ArticleIdList": ["10.48048/tis.2023.4293"]}, {"Citation": "Shi Y., Goodisman J., Dabrowiak J.C. Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin. Inorg. Chem. 2013;52:9418\u20139426. doi: 10.1021/ic400989v.", "ArticleIdList": ["10.1021/ic400989v", "23889547"]}, {"Citation": "Yoon S.J., Moon Y.J., Chun H.J., Yang D.H. Doxorubicin\u00b7Hydrochloride/Cisplatin-Loaded Hydrogel/Nanosized (2-Hydroxypropyl)-Beta-Cyclodextrin Local Drug-Delivery System for Osteosarcoma Treatment In Vivo. Nanomaterials. 2019;9:1652. doi: 10.3390/nano9121652.", "ArticleIdList": ["10.3390/nano9121652", "PMC6956151", "31766334"]}, {"Citation": "Zhu W., Li Y., Liu L., Chen Y., Xi F. Supramolecular hydrogels as a universal scaffold for stepwise delivering Dox and Dox/cisplatin loaded block copolymer micelles. Int. J. Pharm. 2012;437:11\u201319. doi: 10.1016/j.ijpharm.2012.08.007.", "ArticleIdList": ["10.1016/j.ijpharm.2012.08.007", "22902390"]}, {"Citation": "H\u0103d\u0103rug\u0103 D.I., H\u0103d\u0103rug\u0103 N.G., Bandur G.N., Isengard H.-D. Water content of flavonoid/cyclodextrin nanoparticles: Relationship with the structural descriptors of biologically active compounds. Food Chem. 2012;132:1651\u20131659. doi: 10.1016/j.foodchem.2011.06.004.", "ArticleIdList": ["10.1016/j.foodchem.2011.06.004"]}, {"Citation": "H\u0103d\u0103rug\u0103 N.G., H\u0103d\u0103rug\u0103 D.I. Stilbenes and Its Derivatives and Glycosides. In: Jafari S.M., Rashidinejad A., Simal-Gandara J., editors. Handbook of Food Bioactive Ingredients: Properties and Applications. Springer Nature Switzerland AG; Cham, Swizterland: 2023. pp. 1\u201363.", "ArticleIdList": ["10.1007/978-3-030-81404-5_14-1"]}, {"Citation": "H\u0103d\u0103rug\u0103 N.G., Popescu G., Gligor-(Pane) D., Mitroi C.L., Stanciu S.M., H\u0103d\u0103rug\u0103 D.I. Discrimination of \u03b2-cyclodextrin/hazelnut (Corylus avellana L.) oil/flavonoid glycoside and flavonolignan ternary complexes by Fourier-transform infrared spectroscopy coupled with principal component analysis. Beilstein J. Org. Chem. 2023;19:380\u2013398. doi: 10.3762/bjoc.19.30.", "ArticleIdList": ["10.3762/bjoc.19.30", "PMC10071518", "37025496"]}, {"Citation": "Rivi\u015f A., H\u0103d\u0103rug\u0103 N.G., G\u00e2rban Z., H\u0103d\u0103rug\u0103 D.I. Titanocene/cyclodextrin supramolecular systems: A theoretical approach. Chem. Cent. J. 2012;6:129. doi: 10.1186/1752-153X-6-129.", "ArticleIdList": ["10.1186/1752-153X-6-129", "PMC3537657", "23122334"]}, {"Citation": "Halsey L.G., Curran-Everett D., Vowler S.L., Drummond G.B. The fickle P value generates irreproducible results. Nat. Methods. 2015;12:179\u2013185. doi: 10.1038/nmeth.3288.", "ArticleIdList": ["10.1038/nmeth.3288", "25719825"]}, {"Citation": "Hofmann M., Meyer-Nieberg S. Time to dispense with the p-value in OR? Rationale and implications of the statement of the American Statistical Association (ASA) on p-values. Cent. Eur. J. Oper. Res. 2018;26:193\u2013214. doi: 10.1007/s10100-017-0484-9.", "ArticleIdList": ["10.1007/s10100-017-0484-9"]}, {"Citation": "Goodman S. A Dirty Dozen: Twelve P-Value Misconceptions. Semin. Hematol. 2008;45:135\u2013140. doi: 10.1053/j.seminhematol.2008.04.003.", "ArticleIdList": ["10.1053/j.seminhematol.2008.04.003", "18582619"]}, {"Citation": "Tukey J.W. Exploratory Data Analysis. Addison-Wesley Publ. Co.; Reading, MA, USA: 1977."}, {"Citation": "McBride G., Cole R.G., Westbrooke I., Jowett I. Assessing environmentally significant effects: A better strength-of-evidence than a single P value? Environ. Monit. Assess. 2014;186:2729\u20132740. doi: 10.1007/s10661-013-3574-8.", "ArticleIdList": ["10.1007/s10661-013-3574-8", "24352867"]}, {"Citation": "Abdi H., Williams L.J. Tukey\u2019s Honestly Significant Difference (HSD) Test. In: Salkind N., editor. Encyclopedia of Research Design. Sage; Thousand Oaks, CA, USA: 2010. pp. 1\u20135."}, {"Citation": "Nanda A., Mohapatra B.B., Mahapatra A.P.K., Mahapatra A.P.K., Mahapatra A.P.K. Multiple comparison test by Tukey\u2019s honestly significant difference (HSD): Do the confident level control type I error. Int. J. Stat. Appl. Math. 2021;6:59\u201365. doi: 10.22271/maths.2021.v6.i1a.636.", "ArticleIdList": ["10.22271/maths.2021.v6.i1a.636"]}, {"Citation": "Obinna V.C., Agu G.O. Haematological and Biochemical Profile of Wistar Rats Exposed to Chloroform Stem Extract of Portulaca oleracea Linn. (Purslane) Annu. Res. Rev. Biol. 2021;36:69076. doi: 10.9734/arrb/2021/v36i730394.", "ArticleIdList": ["10.9734/arrb/2021/v36i730394"]}, {"Citation": "Femi-Oloye O.P., Owoloye A., Olatunji-Ojo A.M., Abiodun A.C., Adewumi B., Ibitoye B.O., Oloye F.F., Izegaegbe J.I., Adebayo T.M., Adedoja A.J., et al. Effects of commonly used food additives on haematological parameters of Wistar rats. Heliyon. 2020;6:e05221. doi: 10.1016/j.heliyon.2020.e05221.", "ArticleIdList": ["10.1016/j.heliyon.2020.e05221", "PMC7569304", "33102847"]}, {"Citation": "Matsuzawa T., Hayashi Y., Nomura M., Unno T., Igarashi T., Furuya T., Sekita K., Ono A., Kurokawa Y., Hayashi Y. A survey of the values of clinical chemistry parameters obtained for a common rat blood sample in ninety-eight Japanese laboratories. J. Toxicol. Sci. 1997;22:25\u201345. doi: 10.2131/jts.22.25.", "ArticleIdList": ["10.2131/jts.22.25", "9076655"]}, {"Citation": "Normal Clinical Chemistry and Hematology Reference Values\u2014Pathology Services, University Animal Care, Quality Care for Research Animals, the University of Arizona.  [(accessed on 3 August 2023)].  Available online:  https://uac.arizona.edu."}, {"Citation": "Balt\u0103 C., H\u0103d\u0103rug\u0103 N.G., Plesa-(Mitar) C.M., Ghibu D., G\u00e2rban G., G\u00e2rban Z., H\u0103d\u0103rug\u0103 D.I. Hematological properties of cisplatin and its Ficaria verna Huds. extracts/\u03b2-cyclodextrin complexes in rats. J. Agroaliment. Process. Technol. 2012;18:358\u2013361."}, {"Citation": "G\u00fcr F.M., Bilgi\u00e7 S. Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel. Tissue Cell. 2023;83:102158. doi: 10.1016/j.tice.2023.102158.", "ArticleIdList": ["10.1016/j.tice.2023.102158", "37459721"]}, {"Citation": "H\u0103d\u0103rug\u0103 N.G., Chiril\u0103 C.A., Szakal R.N., G\u0103lan I.M., Simandi M.D., Bujanc\u0103 G.S., David I., Rivi\u015f A., Stanciu S.M., H\u0103d\u0103rug\u0103 D.I. FTIR\u2013PCA approach on raw and thermally processed chicken lipids stabilized by nano-encapsulation in \u03b2-cyclodextrin. Foods. 2022;11:3632. doi: 10.3390/foods11223632.", "ArticleIdList": ["10.3390/foods11223632", "PMC9689604", "36429225"]}, {"Citation": "H\u0103d\u0103rug\u0103 D.I., H\u0103d\u0103rug\u0103 N.G., Costescu C.I., David I., Gruia A.T. Thermal and oxidative stability of the Ocimum basilicum L. essential oil/\u03b2-cyclodextrin supramolecular system. Beilstein J. Org. Chem. 2014;10:2809\u20132820. doi: 10.3762/bjoc.10.298.", "ArticleIdList": ["10.3762/bjoc.10.298", "PMC4273302", "25550747"]}, {"Citation": "Medeleanu M.A., H\u0103d\u0103rug\u0103 D.I., Muntean C.V., Popescu G., Rada M., Heghe\u015f A., Zippenfening S.E., Lucan-(Banciu) C.A., Velciov A.B., Bandur G.N., et al. Structure-property relationships on recrystallized \u03b2-cyclodextrin solvates: A focus on X-ray diffractometry, FTIR and thermal analyses. Carbohydr. Polym. 2021;265:118079. doi: 10.1016/j.carbpol.2021.118079.", "ArticleIdList": ["10.1016/j.carbpol.2021.118079", "33966843"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "7"}, {"Year": "2023", "Month": "10", "Day": "5"}, {"Year": "2023", "Month": "10", "Day": "7"}, {"Year": "2023", "Month": "10", "Day": "28", "Hour": "11", "Minute": "48"}, {"Year": "2023", "Month": "10", "Day": "28", "Hour": "11", "Minute": "47"}, {"Year": "2023", "Month": "10", "Day": "28", "Hour": "1", "Minute": "8"}, {"Year": "2023", "Month": "10", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["37893100", "PMC10604837", "10.3390/biomedicines11102726", "biomedicines11102726"]}}], "PubmedBookArticle": []}